Cunard Line:企業の戦略・SWOT・財務分析

◆英語タイトル:Cunard Line - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3865
◆発行会社(調査会社):MarketLine
◆発行日:2019年12月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Leisure and Arts
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Cunard Line – Strategy, SWOT and Corporate Finance Report
Summary

Cunard Line – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Cunard Line (Cunard), a subsidiary of Carnival Corporation & PLC, is an operator of luxury cruise line. The company’s cruise liners include Queen Mary 2, Queen Victoria and Queen Elizabeth. It offers five-star dining, luxurious accommodations and white star service across its ships. The company’s cruise liners comprise theatre, spa, library, grills restaurants and a range of entertainment options. Cunard’s grill restaurants provide luxury dining experience with a wide range of cuisine options. Its cruise type includes transatlantic cruises, cruises from Southampton, mini cruises, Mediterranean fly-cruises, world cruises and exotic cruises. The company’s ships primarily sail a variety of seasonal itineraries in Northern Europe, the Mediterranean and the Caribbean/Panama Canal, and traditional transatlantic voyages. Cunard is headquartered in Southampton, the UK.

Scope

- Detailed information on Cunard Line required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Cunard Line in the form of a SWOT analysis
- An in-depth view of the business model of Cunard Line including a breakdown and examination of key business segments
- Intelligence on Cunard Line’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Cunard Line, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Cunard Line and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Cunard Line as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Cunard Line’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Cunard Line: Company Overview
Cunard Line: Overview and Key Facts
Cunard Line: Overview
Cunard Line: Key Facts
Cunard Line: Key Employees
Cunard Line: Major Products and Services
Cunard Line: Company History
Cunard Line: Key Competitors
Cunard Line: Company Analysis
Cunard Line: Business Description
Cunard Line: SWOT Analysis
Cunard Line: SWOT Overview
Cunard Line: Strengths
Cunard Line: Weaknesses
Cunard Line: Opportunities
Cunard Line: Threats
Cunard Line: Recent Developments
Cunard Line: News and Events Summary
Cunard Line: Business Expansion
Cunard Line: Contracts
Cunard Line: Financial Deals
Cunard Line: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Cunard Line: Key Facts
Table 2: Cunard Line: Key Employees
Table 3: Cunard Line: Company History
Table 4: Cunard Line: Key Competitors
Table 5: Cunard Line: News and Events Summary
Table 6: Cunard Line: Business Expansion
Table 7: Cunard Line: Contracts
Table 8: Cunard Line: Financial Deals
Table 9: Cunard Line: Strategy and Operations

★海外企業調査レポート[Cunard Line:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Technology Nexus AB:企業の戦略的SWOT分析
    Technology Nexus AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Oilex Ltd (OEX):石油・ガス:M&Aディール及び事業提携情報
    Summary Oilex Ltd (Oilex) is an oil and gas company that acquires, explores and develops petroleum resources. The company’s projects in Australia include STP-EPA-0106, STP-EPA-0131, and STP-EPA-0107. Its STP-EPA-0106 project is located in onshore north-western Australia. Oilex’s Indian projects are …
  • Opsona Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Opsona Therapeutics Ltd (Opsona) is a drug developing company that conducts research, develops and commercializes new treatment for the autoimmune and inflammatory diseases and cancers. The company's OPN-305 is a humanized antibody used to reduce pro-inflammatory cytokine production that is …
  • Second Sight Medical Products Inc (EYES):医療機器:M&Aディール及び事業提携情報
    Summary Second Sight Medical Products Inc (Second Sight) is a medical device company that develops, manufactures and markets implantable visual prosthetics for blind individuals. The company offers Argus II retinal prosthesis system, a device that restores some functional vision for people suffering …
  • Telecom Plus plc (TEP):企業の財務・戦略的SWOT分析
    Telecom Plus plc (TEP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Exact Sciences Corp (EXAS):企業の財務・戦略的SWOT分析
    Exact Sciences Corp (EXAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Aqeri International AB:企業の戦略的SWOT分析
    Aqeri International AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Praj Industries Ltd (PRAJIND):企業の財務・戦略的SWOT分析
    Summary Praj Industries Ltd (Praj) is a process and project engineering company that manufactures, develops, and markets biodiesel and ethanol. The company offers solutions for beverage alcohol and bioethanol plant, brewery, water and wastewater treatment plant, critical process equipment and system …
  • China Resources Gas Group Ltd (1193):企業の財務・戦略的SWOT分析
    China Resources Gas Group Ltd (1193) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Immupharma Plc (IMM):製薬・医療:M&Aディール及び事業提携情報
    Summary ImmuPharma Plc (ImmuPharma) develops novel drugs for the treatment of serious medical conditions with unmet medical need. ImmuPharma develops drugs for the treatment of lupus, cancer, moderate to severe pain, highly resistant hospital-acquired infections such as methicillin-resistant staphyl …
  • National Real Estate Company K.S.C.:企業の戦略・SWOT・財務情報
    National Real Estate Company K.S.C. - Strategy, SWOT and Corporate Finance Report Summary National Real Estate Company K.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Newfield Exploration Company (NFX)-石油・ガス分野:企業M&A・提携分析
    Summary Newfield Exploration Company (Newfield) is an independent upstream company. The company focuses on onshore large scale, liquids-rich resource plays. Its domestic assets are in the Anadarko and Arkoma basins of Oklahoma, the Williston Basin of North Dakota and the Uinta Basin of Utah. The com …
  • Koninklijke Philips NV (PHIA):企業の製品パイプライン分析
    Summary Koninklijke Philips NV (Philips) is a diversified technology company that develops and manufactures medical systems and consumer electronics products. The company offers products and solutions in the areas of diagnostic imaging, enterprise diagnostic informatics, image-guided therapy, ultras …
  • UMN Pharma Inc (4585):企業の財務・戦略的SWOT分析
    Summary UMN Pharma Inc (UMN Pharma) is a biopharmaceutical company that manufactures therapeutic for muscular dystrophy, diabetes and influenza. The company’s products include UMN-0501, UMN-0502, UMN-2003, UMN-0901 and UMN-2002, among others. Its UMN-0502 is a seasonal influenza vaccine. UMN Pharma’ …
  • Virgin Active Limited:企業の戦略・SWOT・財務分析
    Virgin Active Limited - Strategy, SWOT and Corporate Finance Report Summary Virgin Active Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • MediciNova Inc (MNOV)-製薬・医療分野:企業M&A・提携分析
    Summary MediciNova Inc (MediciNova) is a biopharmaceutical company, which focuses on acquiring, and developing novel, small-molecule therapeutics for the treatment of neurology, respiratory, and liver diseases. MediciNova’s developmental pipeline includes core programs such as MN-001, for the treatm …
  • Melinta Therapeutics Inc (MLNT):製薬・医療:M&Aディール及び事業提携情報
    Summary Melinta Therapeutics Inc (Melinta) is a biopharmaceutical company that focuses on the development of novel antibiotics. Its drugs are intended to treat the various bacterial infections. The company's lead product Baxdela (delafloxacin) has been approved by the US FDA as an IV treatment for s …
  • Pt Sarihusada Generasi Mahardhika:企業の戦略・SWOT・財務分析
    Pt Sarihusada Generasi Mahardhika - Strategy, SWOT and Corporate Finance Report Summary Pt Sarihusada Generasi Mahardhika - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • PageGroup plc (PAGE):企業の財務・戦略的SWOT分析
    PageGroup plc (PAGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Viamet Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Viamet Pharmaceuticals Inc (Viamet), a subsidiary of Viamet Pharmaceuticals Holdings LLC, discovers and develops novel medicinal drugs based on metalloenzyme chemistry and biology technology platform. Its product pipeline includes clinical-stage compounds such as VT-1161, an oral inhibitor u …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆